Public-registry site landscape for NCT07722494, a Colorectal Cancer study sponsored by Innovent Biologics (Suzhou) Co. Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07722494 (registry record) |
| Sponsor | Innovent Biologics (Suzhou) Co. Ltd. |
| Condition(s) | Colorectal Cancer |
| Phase | PHASE3 |
| Listed sites | 2 |
| Site countries | China |
At Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — one of the facilities listed on this trial — 13 other studies are actively recruiting Colorectal Cancer patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07722494 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →